We advised Sigachi Industries Limited, an industry leader in the field of pharma excipients, nutra and food ingredients and the largest manufacturer worldwide of microcrystalline cellulose. The transaction involves acquisition of 80% shareholding in Trimax Bio Sciences Private Limited, to enable Sigachi Industries Limited to foray into the API business and to solidify its position as a leading player in the healthcare industry, catering to the growing demand for high-quality APIs.
We acted as the sole legal counsel to Sigachi Industries Limited.
The Team
Vihang Virkar
Partner
Monika Deshmukh
Executive Director
Pooja Shah
Senior Associate
Vanshikha Choraria
Associate
The team was supported by Senior Associate – Shivani Shah and Associates – Rishabha Sharma, Disha Jain, and Rozel Arora.